Macrolides in severe community-acquired pneumonia and sepsis

Marcos I. Restrepo, Eric M. Mortensen, Grant W. Waterer, Richard G. Wunderink, Antonio Anzueto

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

More than 750,000 cases of severe sepsis occur annually (Angus et al. 2001), making the incidence of severe sepsis higher than that of breast cancer, AIDS, or first myocardial infarction. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised patients, and the increasing use of invasive procedures, and to a lesser extent, because of antibiotic resistance among pathogens. In the United States alone, almost $17 billion is spent each year treating patients with sepsis (Angus et al. 2001). Despite advances in care, more than 210,000 patients with severe sepsis die annually (Angus et al. 2001). The mortality rate associated with severe sepsis remains between 20% and 80% (Zeni et al. 1997). Even dysfunction of a single organ places patients at a significant risk for dying (about 20%), with mortality rates increasing approximately 15-20% for each additional dysfunctional organ (Vincent et al. 1998). Mortality rates are highest (ranging from 50 to 80%) for patients with cardiovascular compromise (septic shock) (Rangel-Frausto et al. 1995). Respiratory infections, whether community- or hospital-acquired account for the most sepsis cases (Angus et al. 2001; Bernard et al. 2001; Martin et al. 2003). Community-acquired pneumonia (CAP) is one the most common reasons for sepsis and is itself, independent of sepsis, the seventh leading cause of death and the leading cause of infectious death in the United States (Hoyert et al. 2005).

Original languageEnglish (US)
Title of host publicationSepsis: New Strategies for Management
PublisherSpringer Berlin Heidelberg
Pages1-17
Number of pages17
ISBN (Print)9783540790006
DOIs
StatePublished - 2008

Fingerprint

Macrolides
Sepsis
Pneumonia
Mortality
Cause of Death
Incidence
Community Hospital
Immunocompromised Host
Microbial Drug Resistance
Septic Shock
Respiratory Tract Infections
Acquired Immunodeficiency Syndrome
Myocardial Infarction
Breast Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Restrepo, M. I., Mortensen, E. M., Waterer, G. W., Wunderink, R. G., & Anzueto, A. (2008). Macrolides in severe community-acquired pneumonia and sepsis. In Sepsis: New Strategies for Management (pp. 1-17). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-79001-3_1

Macrolides in severe community-acquired pneumonia and sepsis. / Restrepo, Marcos I.; Mortensen, Eric M.; Waterer, Grant W.; Wunderink, Richard G.; Anzueto, Antonio.

Sepsis: New Strategies for Management. Springer Berlin Heidelberg, 2008. p. 1-17.

Research output: Chapter in Book/Report/Conference proceedingChapter

Restrepo, MI, Mortensen, EM, Waterer, GW, Wunderink, RG & Anzueto, A 2008, Macrolides in severe community-acquired pneumonia and sepsis. in Sepsis: New Strategies for Management. Springer Berlin Heidelberg, pp. 1-17. https://doi.org/10.1007/978-3-540-79001-3_1
Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Anzueto A. Macrolides in severe community-acquired pneumonia and sepsis. In Sepsis: New Strategies for Management. Springer Berlin Heidelberg. 2008. p. 1-17 https://doi.org/10.1007/978-3-540-79001-3_1
Restrepo, Marcos I. ; Mortensen, Eric M. ; Waterer, Grant W. ; Wunderink, Richard G. ; Anzueto, Antonio. / Macrolides in severe community-acquired pneumonia and sepsis. Sepsis: New Strategies for Management. Springer Berlin Heidelberg, 2008. pp. 1-17
@inbook{17143b88af7a4e0dae1c9946a40cedea,
title = "Macrolides in severe community-acquired pneumonia and sepsis",
abstract = "More than 750,000 cases of severe sepsis occur annually (Angus et al. 2001), making the incidence of severe sepsis higher than that of breast cancer, AIDS, or first myocardial infarction. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised patients, and the increasing use of invasive procedures, and to a lesser extent, because of antibiotic resistance among pathogens. In the United States alone, almost $17 billion is spent each year treating patients with sepsis (Angus et al. 2001). Despite advances in care, more than 210,000 patients with severe sepsis die annually (Angus et al. 2001). The mortality rate associated with severe sepsis remains between 20{\%} and 80{\%} (Zeni et al. 1997). Even dysfunction of a single organ places patients at a significant risk for dying (about 20{\%}), with mortality rates increasing approximately 15-20{\%} for each additional dysfunctional organ (Vincent et al. 1998). Mortality rates are highest (ranging from 50 to 80{\%}) for patients with cardiovascular compromise (septic shock) (Rangel-Frausto et al. 1995). Respiratory infections, whether community- or hospital-acquired account for the most sepsis cases (Angus et al. 2001; Bernard et al. 2001; Martin et al. 2003). Community-acquired pneumonia (CAP) is one the most common reasons for sepsis and is itself, independent of sepsis, the seventh leading cause of death and the leading cause of infectious death in the United States (Hoyert et al. 2005).",
author = "Restrepo, {Marcos I.} and Mortensen, {Eric M.} and Waterer, {Grant W.} and Wunderink, {Richard G.} and Antonio Anzueto",
year = "2008",
doi = "10.1007/978-3-540-79001-3_1",
language = "English (US)",
isbn = "9783540790006",
pages = "1--17",
booktitle = "Sepsis: New Strategies for Management",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Macrolides in severe community-acquired pneumonia and sepsis

AU - Restrepo, Marcos I.

AU - Mortensen, Eric M.

AU - Waterer, Grant W.

AU - Wunderink, Richard G.

AU - Anzueto, Antonio

PY - 2008

Y1 - 2008

N2 - More than 750,000 cases of severe sepsis occur annually (Angus et al. 2001), making the incidence of severe sepsis higher than that of breast cancer, AIDS, or first myocardial infarction. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised patients, and the increasing use of invasive procedures, and to a lesser extent, because of antibiotic resistance among pathogens. In the United States alone, almost $17 billion is spent each year treating patients with sepsis (Angus et al. 2001). Despite advances in care, more than 210,000 patients with severe sepsis die annually (Angus et al. 2001). The mortality rate associated with severe sepsis remains between 20% and 80% (Zeni et al. 1997). Even dysfunction of a single organ places patients at a significant risk for dying (about 20%), with mortality rates increasing approximately 15-20% for each additional dysfunctional organ (Vincent et al. 1998). Mortality rates are highest (ranging from 50 to 80%) for patients with cardiovascular compromise (septic shock) (Rangel-Frausto et al. 1995). Respiratory infections, whether community- or hospital-acquired account for the most sepsis cases (Angus et al. 2001; Bernard et al. 2001; Martin et al. 2003). Community-acquired pneumonia (CAP) is one the most common reasons for sepsis and is itself, independent of sepsis, the seventh leading cause of death and the leading cause of infectious death in the United States (Hoyert et al. 2005).

AB - More than 750,000 cases of severe sepsis occur annually (Angus et al. 2001), making the incidence of severe sepsis higher than that of breast cancer, AIDS, or first myocardial infarction. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised patients, and the increasing use of invasive procedures, and to a lesser extent, because of antibiotic resistance among pathogens. In the United States alone, almost $17 billion is spent each year treating patients with sepsis (Angus et al. 2001). Despite advances in care, more than 210,000 patients with severe sepsis die annually (Angus et al. 2001). The mortality rate associated with severe sepsis remains between 20% and 80% (Zeni et al. 1997). Even dysfunction of a single organ places patients at a significant risk for dying (about 20%), with mortality rates increasing approximately 15-20% for each additional dysfunctional organ (Vincent et al. 1998). Mortality rates are highest (ranging from 50 to 80%) for patients with cardiovascular compromise (septic shock) (Rangel-Frausto et al. 1995). Respiratory infections, whether community- or hospital-acquired account for the most sepsis cases (Angus et al. 2001; Bernard et al. 2001; Martin et al. 2003). Community-acquired pneumonia (CAP) is one the most common reasons for sepsis and is itself, independent of sepsis, the seventh leading cause of death and the leading cause of infectious death in the United States (Hoyert et al. 2005).

UR - http://www.scopus.com/inward/record.url?scp=84892780740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892780740&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-79001-3_1

DO - 10.1007/978-3-540-79001-3_1

M3 - Chapter

SN - 9783540790006

SP - 1

EP - 17

BT - Sepsis: New Strategies for Management

PB - Springer Berlin Heidelberg

ER -